Niki BioSolutions, Inc.(NIKI)

Biotechnology · Princeton, NJ

$4.69-0.04 (-0.81%)

Delayed quote: Oct 6, 2026, 2:38 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T18:52:21.993Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:52:21.993Z.

Quote observation: 2026-10-06T18:38:03.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 381,940
Total debt · period ending 2025-12-31: 3,442,928
Cash · period ending 2025-12-31: 3,452,891
TTM operating EBITDA · period ending 2025-12-31: N/A

FMP input reference: 05f4ae4a030aaca39f2691a5695262832c6d48704f11c5316ed8238ac0b3761e

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NIKI EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

NIKI Competitors' EV/EBITDA Ratio

NIKI

Niki BioSolutions, Inc.

Current

Market Cap

$381940.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VRAX

Virax Biolabs Group Limited

vs NIKI

Market Cap

$357350.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XRTX

XORTX Therapeutics Inc.

vs NIKI

Market Cap

$484571.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SPRC

SciSparc Ltd.

vs NIKI

Market Cap

$242924.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VIVS

VivoSim Labs, Inc.

vs NIKI

Market Cap

$530421.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs NIKI

Market Cap

$552749.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLXN

Silexion Therapeutics Ltd.

vs NIKI

Market Cap

$109777.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDT

CDT Equity Inc.

vs NIKI

Market Cap

$663982.00

EV/EBITDA Ratio

4.13x

TTM Avg

10.27x

3Y Avg

9.51x

5Y Avg

9.51x

PBM

Psyence Biomedical Ltd.

vs NIKI

Market Cap

$96215.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRFX

PRF Technologies Ltd.

vs NIKI

Market Cap

$70876.00

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Niki BioSolutions, Inc. (NIKI)	$381940.00	N/A	N/A	N/A	N/A
Virax Biolabs Group Limited (VRAX)vs ›	$357350.00	N/A	N/A	N/A	N/A
XORTX Therapeutics Inc. (XRTX)vs ›	$484571.00	N/A	N/A	N/A	N/A
SciSparc Ltd. (SPRC)vs ›	$242924.00	N/A	N/A	N/A	N/A
VivoSim Labs, Inc. (VIVS)vs ›	$530421.00	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$552749.00	N/A	N/A	N/A	N/A
Silexion Therapeutics Ltd. (SLXN)vs ›	$109777.00	N/A	N/A	N/A	N/A
CDT Equity Inc. (CDT)vs ›	$663982.00	4.13x	10.27x	9.51x	9.51x
Psyence Biomedical Ltd. (PBM)vs ›	$96215.00	N/A	N/A	N/A	N/A
PRF Technologies Ltd. (PRFX)vs ›	$70876.00	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics